Largest biotech companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 20 biotech companies in the United States ranked by total assets, at NOK 882.7B, ahead of Gilead Sciences (NOK 575.2B) and Biogen (NOK 286.9B). Figures as of 20 Nov 2026, 14:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- AmgenNOK 882.7B
- Median
- NOK 23.8B
- Combined market value
- NOK 7.28T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | NOK 882.7B | NOK 2.35T | NOK 4,337.37 | 2.02% up | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | NOK 575.2B | NOK 2.06T | NOK 1,657.28 | 2.13% up | 31% up | ||
| 3 | BiogenBIIB · Health Care | NOK 286.9B | NOK 360.6B | NOK 2,439.25 | 1.29% up | 41% up | ||
| 4 | ModernaMRNA · Health Care | NOK 120.2B | NOK 819.1B | NOK 2,024.37 | 4.22% up | 740% up | ||
| 5 | Neurocrine BiosciencesNBIX · Health Care | NOK 45.1B | NOK 154.5B | NOK 1,526.61 | 0.04% up | 10% up | ||
| 6 | VaxcytePCVX · Health Care | NOK 29.3B | NOK 89.1B | NOK 562.86 | 1.03% down | 22% up | ||
| 7 | RepligenRGEN · Health Care | NOK 28.7B | NOK 104.7B | NOK 1,637.11 | 1.34% down | 5% up | ||
| 8 | ExelixisEXEL · Health Care | NOK 27.7B | NOK 158B | NOK 647.49 | 0.93% up | 55% up | ||
| 9 | Bio-TechneTECH · Health Care | NOK 25.2B | NOK 111.3B | NOK 708.78 | 0.05% up | 18% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | NOK 24.6B | NOK 103.7B | NOK 909.38 | 0.30% up | 32% up | ||
| 11 | Revolution MedicinesRVMD · Health Care | NOK 22.9B | NOK 346.5B | NOK 1,602.13 | 3.12% up | 125% up | ||
| 12 | Kymera TherapeuticsKYMR · Health Care | NOK 17B | NOK 97.8B | NOK 1,145.59 | 1.53% down | 81% up | ||
| 13 | Krystal BiotechKRYS · Health Care | NOK 13B | NOK 92.1B | NOK 3,108.57 | 1.01% up | 49% up | ||
| 14 | ImmunovantIMVT · Health Care | NOK 9.3B | NOK 65.1B | NOK 314.46 | 0.77% down | 44% up | ||
| 15 | CG OncologyCGON · Health Care | NOK 7.7B | NOK 71.6B | NOK 801.31 | 0.40% up | 93% up | ||
| 16 | Twist BioscienceTWST · Health Care | NOK 6.3B | NOK 68.8B | NOK 1,008.58 | 7.27% down | 291% up | ||
| 17 | Adaptive BiotechnologiesADPT · Health Care | NOK 5B | NOK 44.4B | NOK 274.27 | 0.34% up | 51% up | ||
| 18 | ImmunityBioIBRX · Health Care | NOK 4.9B | NOK 66.3B | NOK 62.37 | 2.59% down | 216% up | ||
| 19 | Scholar Rock HoldingSRRK · Health Care | NOK 3.9B | NOK 60B | NOK 492.01 | 0.24% up | 25% up | ||
| 20 | Kodiak SciencesKOD · Health Care | NOK 3.4B | NOK 62.4B | NOK 953.52 | 0.05% down | 371% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7447 NOK).
Questions and answers
Which biotech companies in the United States rank first by total assets?
Amgen (NOK 882.7B), Gilead Sciences (NOK 575.2B) and Biogen (NOK 286.9B) are the top three of the 20 biotech companies in the United States ranked by total assets as of 20 Nov 2026, 14:47 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by total assets.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by total assets have a combined market value of NOK 7.28T as of 20 Nov 2026, 14:47 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.